Jeffrey Tuch - 01 Apr 2026 Form 3 Insider Report for Guardian Pharmacy Services, Inc. (GRDN)

Source evidence Original filing metadata and source links for verification. 3 source fields
SEC form
3
Accepted by SEC
13 Apr 2026, 17:00:04 UTC
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Douglas Towns, Attorney-in-Fact

Key filing fact

Jeffrey Tuch filed Form 3 for Guardian Pharmacy Services, Inc. (GRDN) on 13 Apr 2026.

Key facts

  • This page summarizes Jeffrey Tuch's Form 3 filing for Guardian Pharmacy Services, Inc. (GRDN).
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 13 Apr 2026, 17:00.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0002128003 Primary reporting owner

Tuch Jeffrey

Relationship
Senior Vice President, Purchasing & Pricing Analytics Exhibit 24.1 - Power of Attorney
Address
300 GALLERIA PARKWAY SE, SUITE 800, ATLANTA
Signature
/s/ Douglas Towns, Attorney-in-Fact
Signature date
13 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GRDN holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
176,269
Date
01 Apr 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

GRDN holding Derivative

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Apr 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
55,578
Exercise price
Footnotes
F2
GRDN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Apr 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
25,000
Exercise price
$34.59
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Also includes 5,063 and 4,476 restricted stock units that, upon vesting in full on February 14, 2028 and March 1, 2029, respectively, are settled on a one-for-one basis in shares of Guardian Pharmacy Services, Inc.'s (the "Issuer") Class A common stock.

Footnote F2

Pursuant to the Issuer's Amended and Restated Certificate of Incorporation, the Reporting Person's shares of the Issuer's Class B common stock automatically convert into shares of the Issuer's Class A common stock, on a one-for-one basis, on September 27, 2026.

Footnote F3

This option shall vest and become exercisable in full on February 11, 2029.

SEC remarks

Senior Vice President, Purchasing & Pricing Analytics Exhibit 24.1 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .